Related Experiment Video
Updated: May 15, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Applications and challenges of multivalent recombinant vaccines
1Institute of Molecular Biology; University of Zürich-Irchel; Zürich, Switzerland; Current affiliation: Consultant; Life Sciences and Vaccines; Bern, Switzerland.
Novel vaccine technologies using recombinant viral vectors effectively stimulate immune responses. These advanced delivery systems show promise for prophylactic and therapeutic vaccines, including those targeting human immunodeficiency virus (HIV).
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- Antigen/gene delivery systems are crucial for developing new vaccines.
- Recombinant viral vectors, using attenuated viruses as carriers, mimic natural infections to stimulate the immune system.
- These vectors are similar to DNA vaccines but offer efficient immune stimulation.
Purpose of the Study:
- To assess novel antigen-delivery technologies for vaccine development.
- To evaluate the potential of recombinant viral vectors, particularly measles virus vectors, for prophylactic and therapeutic applications.
- To analyze the efficacy of these technologies against human immunodeficiency virus (HIV).
Main Methods:
- Review of existing research on antigen/gene delivery systems.
- Analysis of recombinant viral vector technology, including their mechanism of action.
- Assessment of safety profiles and immune response induction by live attenuated virus vaccines.
Main Results:
- Recombinant viral vectors efficiently stimulate the immune system by mimicking natural infections.
- Live attenuated virus vaccines induce broad, strong, and persistent immune responses with acceptable safety.
- Measles virus vectors may leverage existing industrial and clinical experience.
Conclusions:
- Recombinant viral vectors represent a promising platform for novel vaccine candidates.
- These technologies offer potential for both prophylactic and therapeutic interventions, including for HIV.
- The combination of potent immune stimulation and safety makes live attenuated virus vaccines highly valuable.
Related Concept Videos
Cross-reactivity
Vaccinations
Vaccines
Recombinant DNA
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Viral Recombination

